Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

BCP Week2 > Clin Med/Pathophys > Flashcards

Clin Med/Pathophys Flashcards

1
Q

hemophilia

A

A/B are congenital, X linked recessive deficiencies in coagulation factors VIII / IV. severe cases present in infant males w spontaneous bleeding, mild cases present with significant hemostatic events (surgery or trauma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Deep Vein Thrombosis (DVT)

A

results from blood clot formation within large veins in the legs/pelvis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

thrombocytopenia

A

relative decrease in platelets in the blood with a platelet count <100,000 (normal is 150,000-300,000). characteristically produce petechial and purpuric lesions and bleeding from mucous surfaces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pulmonary embolism

A

blockage of the main artery of hoteling or one of its branches by a clot formation that has formed elsewhere and traveled through the bloodstream. most commonly results from DVT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

vit K deficiency etiology

A

deficient dietary intake, malabsorption, decreased production by intestinal bacteria, primary liver dz depletes stores

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

vit K deficiency pathophys

A

normally it k reductase assists in conversion of gamma-carboxyglutamic acid necessary for factors II, VII, IX, X. if deficient in bit k, clotting factor levels low, and will have prolonged PT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

vit K deficiency s/sxs

A

bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

vit K deficiency mgmt

A

vit K PO or IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

vit K deficiency prognosis

A

improvement in PT in 1 day w PO; 8-10hrs w IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

disseminated intravascular coagulation (DIC) etiology

A

depletion of coagulation factor d/t bacterial sepsis, leukemia, lymphoma, or massive hemorrhage, burns, trauma, pregnancy, snake bites. concurrent uncontrolled generation of thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

disseminated intravascular coagulation (DIC) pathophys

A

widespread intravascular fibrin formation: systemic fibrin deposition in small and medium vessels. massive bleeding d/t platelet and clotting factor depletion. (the clots are blocking small vessels, and all the clotting factors are being used up in those vessels, and not where they are actually needed.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

disseminated intravascular coagulation (DIC) s/sxs

A

depends on magnitude of hemostasis imbalance: ranges from venipuncture oozing/ecchymosis/petechiae to uncontrolled bleeding throughout entire circulatory system. The clots can occlude blood flow to areas of body, as well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

disseminated intravascular coagulation (DIC) dx workup

A 
increased PT & aPTT. 
thrombocytopenia.
decreased fibrinogen levels.
increase in fibrin degradation products.
schistocytes on smear (fragmented RBCs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

disseminated intravascular coagulation (DIC) mgmt

A

treat underlying cause. in high risk pts, can transfuse platelets, cryoprecipitate (for fibrinogen), fresh frozen plasma and packed RBCs. Heparin for clots.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

coagulopathy of liver disease etiology

A

cirrhosis or other hepatopathologies leading to impaired hepatic function. decreased synthesis of clotting factors II, VII, V, IX, and fibrinogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

coagulopathy of liver disease pathophys

A

fewer clotting factors available = net decrease in clotting ability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

coagulopathy of liver disease s/sxs

A

bleeding induced by any stressors. typically asymptomatic with incidentally finding on coagulation lab studies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

coagulopathy of liver disease mgmt

A

FFP infusion if active bleeding present. cryoprecipitate if bleeding + fibrinogen level low. liver transplant. recombinant human activated factor VII.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

aplastic anemia etiology

A

bone marrow failure from suppression or injury to hematopoietic stem cells. inability to produce mature RBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

aplastic anemia pathophys

A

most common cause is autoimmune suppression of hematopoiesis by a T cell mediated cellular mechanism “idiopathic” aplastic anemia. SLE can cause stem cell dysfunction through IgG autoantibody.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

aplastic anemia s/sxs

A

anemia, fatigue/weakness, neutropenia leads to frequent infections, thrombocytopenia causes mucosal and skin bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

aplastic anemia dx workup

A

pancytopenia, anemia also associated with reticulocytopenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

aplastic anemia mgmt

A

supportive care (erythropoietic and/or myeloid growth factors); severe cases may require BMT in meds, immunosuppression in adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

aplastic anemia complications

A

infection, bleeding disorders, anemia, death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

aplastic anemia prognosis

A

severe cases are rapidly fatal if left untreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

immune thrombocytopenic purpura (ITP) etiology

A

hemorrhagic syndrome with diverse causes that can occur in an acute or chronic form. characterized by reduction in # of circulating platelets, abundant megakaryoctytes in the bone marrow, and a shortened platelet life span. may be idiopathic or secondary to a lymphoproliferative disorder, drugs or toxins, bacterial or viral infection, SLE, or other conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

immune thrombocytopenic purpura (ITP)pathophys

A

circulating antiplatelet IgG autoantibody usually directed against a membrane protein, which is the fibrinogen receptor (glycoprotein IIb/IIIa). the spleen is primarily the site of platelet destruction and may also be a significant source of autoantibody production.

28
Q

immune thrombocytopenic purpura (ITP) s/sxs

A

acute onset: ecchymosis or showers of petechiae, may have bleeding gums, vaginal bleeding, GI bleeding, hematuria. chronic: insidious onset, often w long hx of bruising easily and menorrhagia. showers of petechiae may occur

29
Q

immune thrombocytopenic purpura (ITP) dx workup

A

labs: platelet count is mod to severely decreased. WBC & RBC usually normal although iron deficiency anemia may be present as a result of bleeding. bone marrow shows increased # of large megakaryocytes without platelet budding. bleeding time is prolonged. capillary fragility greatly increased. poor clot retraction. PTT/PT, and coat time are normal.

30
Q

immune thrombocytopenic purpura (ITP) mgmt

A

depends on age of pt, severity of dz, duration of thrombocytopneia, and clinical variant. secondary immune thrombocytopenia are best managed by tx the underlying primary disorder. pts with mild or no sxs don’t nd tx but should avoid contact sports, elective surgeries, and unessential meds. corticosteroids can be used in pts with mod to severe purpura of short duration

31
Q

thrombotic thrombocytopenic purport (TTP) etiology

A

ADAMTS13 is reduced in amount or function, allowing persistence of many unusually LARGE vWF multimers; identification of these multimers is diagnostic for TTP.

32
Q

thrombotic thrombocytopenic purport (TTP) pathophys

A

association with ADAMTS-13 (von Willebrand factor [vWF]-cleaving protease) deficiency.
oversized vWF results in platelet over activation leading to thrombus formation.
microthrombi of agglutinated platelets form in microvasculature, occluding arterioles and capillaries.
tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and interferon-gamma act in synergy to induce apoptosis in microvascular endothelial cells, but spare large vessels and pulmonary vessels

33
Q

thrombotic thrombocytopenic purport (TTP) s/sxs

A

classic pentad of TTP = microangiopathic hemolytic anemia, thrombocytopenia, neurological symptoms, renal failure, fever. Usually systemic, but can be localized. most common symptoms include: weakness, anorexia, vomiting, diarrhea, nausea. neurological symptoms: generalized headache, seizures, confusion, coma, transient ischemic attack (TIAs)

34
Q

thrombotic thrombocytopenic purport (TTP) dx workup

A

The hemolytic anemia is characterized by many circulating fragmented erythrocytes in the form of schistocytes and helmet cells. High lactate dehydrogenase (LDH) levels correlate with the severity of the disease. Renal manifestations include microscopic hematuria, rarely gross hematuria, mild to moderate proteinuria, and azotemia with up to 10% of patients having acute renal failure. Renal biopsy may show thrombi with a higher number of platelets and fewer erythrocytes or fibrin.

35
Q

thrombotic thrombocytopenic purport (TTP) mgmt

A 
Corticosteroids + plasma exchange
Low-dose aspirin when platelets recover
Folate supplements
Refractory cases consider: Ritixumab, Cyclophosphamide, Cyclosporine
Splenectomy (severe cases)
Red Cell Transfusion
36
Q

Hemolytic uremic syndrome (HUS) etiology

A

acute renal failure, microangiopathic hemolytic anemia, and thrombocytopenia. It is seen mostly in children and most cases are preceded by hemorrhagic diarrhea (E. Coli is the most common cause). Can present without preceding diarrhea (called DHUS) which is caused by dysregulation of the complement system.

37
Q

Hemolytic uremic syndrome (HUS) pathophys

A

Infection induced by GI illness with diarrhea (EHEC most common cause), has also been associated with invasive pneumococcal disease, or less commonly due to genetic abnormalities affecting the complement pathway. Damage may occur to the endothelial cells, mesangial cells, renal tubular epithelial cells, or monocytes. Proinflammatory and prothrombotic changes in the coagulation pathway may damage the endothelial cells and lead to organ damage.

38
Q

Hemolytic uremic syndrome (HUS) s/sxs

A

Prodromal GI illness with diarrhea, often bloody; symptoms of anemia; neuro symptoms (irritability, lethargy, confusion, stroke, seizures); possible jaundice from hemolysis

39
Q

Hemolytic uremic syndrome (HUS) dx workup

A

Hemolytic anemia – hct <30% with evidence of erythrocyte destruction on peripheral blood smear. Low platelet count. High serum creatinine.

40
Q

Hemolytic uremic syndrome (HUS) mgmt

A

Control of fluid/electrolyte imbalance; RBC transfusion for cardiovascular or respiratory compromise; control of hypertension; dialysis if acute renal failure unresponsive to fluid mgmt; nutritional support; avoid antimotility agents

41
Q

Hemolytic uremic syndrome (HUS) complications

A

Acute renal failure, chronic kidney dz, possible neurologic complications (seizures), acute heart failure, GI perforation or intestinal strictures.

42
Q

Henoch-Schonlein purpura etiology

A

Common systemic vasculitis. More commonly in children. Nonthrombocytopenic purpura caused by inflammation in the blood vessels of the superficial dermis. The dz usually occurs about 10 days after the start of a URI, but no single microorganism or environmental factor has been confirmed as the cause.

43
Q

Henoch-Schonlein purpura pathophys

A

Leukocytoclastic vasculitis and deposition of IgA in the walls of involved blood vessels (typically small vessels). This is a form of vasculitis characterized by IgA dominant immune deposits in the vessel walls, small-vessel involvement (capillaries, venules, arterioles), with skin/gut/renal/and joint manifestations.

44
Q

Henoch-Schonlein purpura s/sxs

A

Acute onset fever, palpable purpura on lower extremities (but can also be seen on hands/arms/trunk/buttocks), abdominal pain (typically colicky and worse after eating, the result of edema of the bowel wall & hemorrhage induced by mesenteric vasculitis), arthritis (most commonly the knees and ankles), hematuria (signals the presence of a glomerular lesion that is usually reversible, although it occasionally may progress to chronic kidney dz).

45
Q

Henoch-Schonlein purpura dx workup

A

Skin biopsy can demonstrate leukocytoclastic vasculitis with IgA deposition. Kidney biopsy shows segmental glomerulonephritis with crescents and mesangial deposition of IgA. Diagnosis should be confirmed by biopsy.

46
Q

Henoch-Schonlein purpura mgmt

A

NSAIDS may alleviate arthralgias, but can aggravate GI symptoms and should be avoided in pts with renal dz. Dapsone (100mg/day) may be effective, maybe through interference with the interactions of IgA and neutrophils, but not really known. Glucocorticoids may help with the joint/GI symptoms, but not with the rash or the renal dz.

47
Q

Henoch-Schonlein purpura prognosis

A

The dz is self-limited most of the time, resolving within a few weeks.

48
Q

Heparin induced thrombocytopenia etiology

A

Thrombocytopenia within 5-10 days of exposure to heparin. Decline in baseline platelet count of 50% or greater. Affects about 3% of pts who are exposed to unfractionated heparin and .6% of pts who are exposed to low-molecular wt heparin

49
Q

Heparin induced thrombocytopenia pathophys

A

Results from the formation of IgG antibodies to heparin-platelet factor 4 complexes. The antibodies then bind platelets, which activates them. This platelet activation leads to both thrombocytopenia and a pro-thrombotic state.

50
Q

Heparin induced thrombocytopenia s/sxs

A

Usually asymptomatic. Bleeding does not usually occur.

51
Q

Heparin induced thrombocytopenia mgmt

A

Immediate discontinuation of the heparin. Platelet transfusions are rarely necessary. Direct Thrombin Inhibitor: Argatroban administered immediately and should be continued until the platelet count has recovered to at least 100,000/mcL, at which point treatment with a vitamin K agonist (Warfarin) should be initiated.

52
Q

Factor VIII deficiency (Hemophilia A) etiology

A

X-linked recessive genetic disorder of clotting factor VIII

53
Q

Factor VIII deficiency (Hemophilia A) pathophys

A

Genetic
Factor VIII needs to be activated in the intrinsic pathway, so that factor X can be cleaved & eventually lead to a fibrin crosslinked clot.
Bleeding results from altered clot formation

54
Q

Factor VIII deficiency (Hemophilia A) s/sxs

A

excessive bleeding w/ or w/o trauma: bleeding into joints, epistaxis.
hemorrhage disproportionate to trauma.
spontaneous hemorrhage (joints, muscles, CNS, GI, & GU all common locations).
family h/o bleeding.

55
Q

Factor VIII deficiency (Hemophilia A) d/dx

A
  • -CALF DIPS mnemonic: Cirrhosis/ liver dz, Asa& other NSAIDs, Leukemia, Factor VIII or IX dysfunction, Disseminated intravascular coagulation, Ideopathic thrombocytopenic purpura, Platelet deficiency, Scurvy
  • -if pt. reports weight loss also: cancer, HIV, RA, SLE, thyroid dz, renal dz
  • -vWD, deficiency of other clotting factors, other hemophilias
56
Q

Factor VIII deficiency (Hemophilia A) mgmt

A

factor VIII,Prompt, aggressive management of hemorrhages, Antihemolytic agents (desmopressin), monoclonal Abs (rituximab)

57
Q

Factor VIII deficiency (Hemophilia A) dx workup

A

CBC: normal to low Hg & platelet count; Factor VIII assay; coagulation study: normal to severely prolonged aPTT w/ a normal PT & bleeding time; Can do genetic testing

58
Q

Von Willibrand Dz (vWF) etiology

A

Autosomal dominant genetic mutation in VWF gene resulting in a quantitative or qualitative defect in vWF; most frequent bleeding disorder (1% prevalence), affects males & females; poor platelet adhesion to vascular walls and deficient factor VIII availability

59
Q

Von Willibrand Dz (vWF) pathophys

A

vWF is made & stored in endothelial cells & platelets. vWF allows platelets to resist the force of blood flow & adhere to exposed collagen of damaged vessel walls. vWF is also a carrier protein for clotting factor VIII.
→ vWF defect prevents proper platelet plug formation and stalls clotting cascade @ factor VIII

60
Q

Von Willibrand Dz (vWF) s/sxs

A

excessive bleeding (easy bruising, bleeding gums, epistaxis, menorrhagia). bleeding into joint is rare.

61
Q

Von Willibrand Dz (vWF) dx workup

A

Prolonged bleeding time, low vWF, low factor VIII procoagulant levels, decreased platelet aggregation when ristocetin is added to plasma

62
Q

Von Willibrand Dz (vWF) mgmt

A

varies depending on type/ subtype involved; Tx & prevent bleeding complications: desmopressin acetate, cryoprecipitate fresh, frozen plasma, factor VIII concentrate

63
Q

Factor IX deficiency (Hemophilia B) etiology

A

X-linked recessive genetic disorder (point mutations & deletions of F9 gene on long arm of X chromosome; generally inherited, but spontaneous mutation & mut. after infection have been seen)

64
Q

Factor IX deficiency (Hemophilia B) pathophys

A

Deficiency of functional factor IX= insufficient thrombin produced by intrinsic pathway, so only platelet plug forms. Lack of crosslinked fibrin clot enables easy bleeding

65
Q

Factor IX deficiency (Hemophilia B) s/sxs

A

excessive bleeding w/ or w/o trauma: bleeding into joints, epistaxis.
hemorrhage disproportionate to trauma.
spontaneous hemorrhage (joints, muscles, CNS, GI, & GU all common locations).
family h/o bleeding.

66
Q

Factor IX deficiency (Hemophilia B) dx workup

A

CBC: normal to low Hg & platelet count; Factor IX assay; coagulation study: normal to severely prolonged aPTT w/ a normal PT & bleeding time; Can do genetic testing

67
Q

Factor IX deficiency (Hemophilia B) mgmt

A

factor IX,Prompt, aggressive management of hemorrhages, Antihemolytic agents (desmopressin), monoclonal Abs (rituximab)

BCP Week2 (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions